Compare Cadila Healthcare with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs FDC LTD. - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE FDC LTD. CADILA HEALTHCARE/
FDC LTD.
 
P/E (TTM) x 18.3 18.2 100.9% View Chart
P/BV x 2.5 2.7 89.6% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 CADILA HEALTHCARE   FDC LTD.
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
FDC LTD.
Mar-18
CADILA HEALTHCARE/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs432319 135.5%   
Low Rs306164 186.8%   
Sales per share (Unadj.) Rs128.661.6 208.6%  
Earnings per share (Unadj.) Rs18.59.9 186.4%  
Cash flow per share (Unadj.) Rs24.412.0 203.9%  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs101.573.2 138.7%  
Shares outstanding (eoy) m1,023.74174.40 587.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.93.9 73.3%   
Avg P/E ratio x19.924.3 82.1%  
P/CF ratio (eoy) x15.120.2 75.0%  
Price / Book Value ratio x3.63.3 110.3%  
Dividend payout %18.90-   
Avg Mkt Cap Rs m378,17042,118 897.9%   
No. of employees `00012.45.5 224.9%   
Total wages/salary Rs m21,2412,167 980.3%   
Avg. sales/employee Rs Th10,585.01,943.7 544.6%   
Avg. wages/employee Rs Th1,707.8391.7 435.9%   
Avg. net profit/employee Rs Th1,526.5313.7 486.6%   
INCOME DATA
Net Sales Rs m131,65610,751 1,224.6%  
Other income Rs m2,011510 394.6%   
Total revenues Rs m133,66711,260 1,187.1%   
Gross profit Rs m29,7312,267 1,311.5%  
Depreciation Rs m5,986351 1,703.5%   
Interest Rs m1,93514 13,821.4%   
Profit before tax Rs m23,8212,411 988.0%   
Minority Interest Rs m469-5 -9,770.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,303671 790.1%   
Profit after tax Rs m18,9871,735 1,094.3%  
Gross profit margin %22.621.1 107.1%  
Effective tax rate %22.327.8 80.0%   
Net profit margin %14.416.1 89.4%  
BALANCE SHEET DATA
Current assets Rs m84,9817,213 1,178.2%   
Current liabilities Rs m73,4252,104 3,490.3%   
Net working cap to sales %8.847.5 18.5%  
Current ratio x1.23.4 33.8%  
Inventory Days Days7554 136.8%  
Debtors Days Days11028 395.1%  
Net fixed assets Rs m133,4936,865 1,944.6%   
Share capital Rs m1,024175 584.5%   
"Free" reserves Rs m102,83912,586 817.1%   
Net worth Rs m103,86312,761 813.9%   
Long term debt Rs m39,4976 658,283.3%   
Total assets Rs m234,83115,041 1,561.2%  
Interest coverage x13.3173.2 7.7%   
Debt to equity ratio x0.40 80,879.8%  
Sales to assets ratio x0.60.7 78.4%   
Return on assets %8.911.6 76.6%  
Return on equity %18.313.6 134.4%  
Return on capital %18.319.0 96.5%  
Exports to sales %012.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA1,327 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m48,4041,889 2,562.6%   
Fx outflow Rs m11,5930-   
Net fx Rs m36,8111,889 1,948.9%   
CASH FLOW
From Operations Rs m28,8231,498 1,923.6%  
From Investments Rs m-57,387201 -28,536.5%  
From Financial Activity Rs m18,846-1,694 -1,112.3%  
Net Cashflow Rs m-7,10510 -68,980.6%  

Share Holding

Indian Promoters % 74.8 68.9 108.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 4.7 176.6%  
FIIs % 5.9 7.5 78.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 19.0 57.9%  
Shareholders   44,069 23,730 185.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   TTK HEALTHCARE  ALEMBIC LTD  WYETH LTD  AJANTA PHARMA  SUVEN LIFESCIENCES  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 181 Points Higher; Energy and Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours but ended their session off day's high.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Nov 20, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS